Get the Stockscreener App
176.76
0.92%
-1.65
After Hours:
176.76
Align Technology Inc stock is traded at $176.76, with a volume of 828.66K.
It is down -0.92% in the last 24 hours and up +1.86% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$178.41
Open:
$176.19
24h Volume:
828.66K
Relative Volume:
0.80
Market Cap:
$12.66B
Revenue:
$4.10B
Net Income/Loss:
$429.89M
P/E Ratio:
29.62
EPS:
5.9668
Net Cash Flow:
$583.65M
1W Performance:
-1.50%
1M Performance:
+1.86%
6M Performance:
+3.07%
1Y Performance:
-8.07%
1-Day Range:
$174.93
$181.17
1-Week Range:
$174.93
$184.62
52-Week Range:
$122.00
$208.31
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALGN
Align Technology Inc
|
176.76 | 12.78B | 4.10B | 429.89M | 583.65M | 5.9668 |
ISRG
Intuitive Surgical Inc
|
345.42 | 142.49B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.17 | 44.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.26 | 34.44B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
39.79 | 34.76B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
198.99 | 29.41B | 5.54B | 1.52B | 1.74B | 10.37 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Mar-17-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-09-26 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Align Technology stock trades near 52-week high as Invisalign demand supports growth - ad-hoc-news.de
How Investors May Respond To Align Technology (ALGN) Losing Its Chief Legal and Regulatory Officer - simplywall.st
ETFs Investing in Align Technology, Inc. Stocks - TradingView
Align Technology stock trades near recent highs as Invisalign demand supports growth - ad-hoc-news.de
(ALGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What to expect from Align Technology’s next quarterly earnings report - MSN
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
ALGN Stock Rises Premarket After Elliott Reportedly Builds ‘Significant’ Stake In Invisalign-Maker - Stocktwits
Align Technology Inc. stock outperforms competitors despite losses on the day - MarketWatch
European Commission – First Formal Antitrust Investigation In The Medical Devices Sector - marketscreener.com
Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year - Yahoo Finance
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry - Yahoo Finance
Executive pay decreases at Invisalign maker Align Technology - Medical Design & Outsourcing
Jitse Marree Net Worth (2026) - GuruFocus
Jaime Holte Richardson Net Worth (2026) - GuruFocus
Align Technology stock holds its ground on scanner and aligner demand - ad-hoc-news.de
Enterprise value to revenue forward of Align Technology, Inc. – NASDAQ:ALGN - TradingView
How Investors May Respond To Align Technology (ALGN) Executive Legal Chief Julie Coletti’s Resignation - simplywall.st
Align Technology (ALGN) Edges Higher, Hovering Between Key Support and ResistanceSentiment Divergence - DonanımHaber
Enterprise value to revenue forward of Align Technology, Inc. – SWB:AFW - TradingView
Align Tech defends practices, pledges cooperation with EU probe - MSN
MY BRILLIANT CAREER | Keeping the world smiling with digital dentistry - TimesLIVE
This Align Technology Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Sahm
AMERICAN ASSETS INC's Align Technology Inc(ALGN) Holding History - GuruFocus
Align Technology, Inc. Announces Resignation of Julie Coletti from Executive Vice President, Chief Legal and Regulatory Officer, Effective August 1, 2026 - marketscreener.com
Align and Carpmaels & Ransford defend PI in dental aligner technology - JUVE Patent
ALGN Initiated Coverage by BMO Capital -- Rated Outperform with $209 Target - GuruFocus
Align Technology (ALGN) Announces Executive Departure - GuruFocus
Here Are Thursday’s Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, Toast, and More - AOL.com
Align Technology 8-K Filing July 2026: Executive Departure and Company Details on NASDAQ - Minichart
Align's Julie Coletti to Leave as Chief Legal and Regulatory Officer for Illumina - TradingView
What to Expect From Align Technology’s Next Quarterly Earnings Report - Barchart.com
Align Technology (ALGN) Stock Looks Undervalued With Earnings Priced About Right - Yahoo Finance
Align Technology Inc (ALGN) Shares Fall 5.7% -- What GF Score of 89 Tells Investors - GuruFocus
Is Align Technology (ALGN) Undervalued Or Overvalued Following Fresh Valuation Research? - Yahoo Finance
Align Technology Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India - AOL.com
Align Technology focuses on digital orthodontics as investors watch Nasdaq listing - Ad Hoc News
Align Technology to Announce Second Quarter 2026 Results on July 29, 2026 - AOL.com
Align's Invisalign Patents Are Infringed But Invalid, Jury Finds - Law360
Federal Circuit Finds Deep Learning Patents Ineligible - IPWatchdog.com
Align Technology Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026 - AOL.com
Invisalign Maker Keeps Win Over AI Dental Image Analysis Patents - Bloomberg Law News
Align Technology Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
When Should You Buy Align Technology, Inc. (NASDAQ:ALGN)? - Moomoo
Align Technology, Inc. (ALGN) Stock Analysis: Navigating Growth with a Potential 13% Upside - DirectorsTalk Interviews
The iTero Element 5D imaging system. How Align Technology pushes chairside 3D scans into everyday US - ad-hoc-news.de
Align Technology highlights digital orthodontics. Align Technology stock aligns long-term growth wit - ad-hoc-news.de
LSV CONSERVATIVE VALUE EQUITY FUND's Align Technology Inc(ALGN) Holding History - GuruFocus
Align Technology outlines long-term growth path as digital orthodontics expands - Ad-hoc-news.de
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Align Technology Inc Stock (ALGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIEGEL SUSAN E | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
10,723 |
| Saia Andrea Lynn | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
17,318 |
| Poul Mojdeh | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| Myong Anne | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
9,830 |
| LARKIN C RAYMOND JR | Director |
May 20 '26 |
Option Exercise |
0.00 |
2,326 |
0 |
27,454 |
| Dallas Kevin J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
16,168 |
| LACOB JOSEPH | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
135,916 |
| Conroy Kevin T | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| MORROW GEORGE J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
5,036 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER |
Feb 20 '26 |
Option Exercise |
0.00 |
7,848 |
0 |
16,085 |
3.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):